Mannatech Inc

Mannatech Inc(MTEX)股票分析

$8.110

+0.050 (+0.62%)收盤時

Loading chart…
最高
8.640
開盤
8.290
成交量加權均價
8.17
成交量
10.84K
市值
13.10M
最低
7.770
成交金額
88.58K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies.

AI 分析 of Mannatech Inc (MTEX)

持有

Mannatech Inc is not a strong buy right now due to its current price of $8.11, which is significantly below its 52-week high of $9.97. The RSI of 41.05 indicates the stock is nearing oversold territory, but the recent 5-day change of -4.25% suggests downward momentum. The upcoming earnings report on November 11 could provide more clarity on its financial health, but the company has faced declining revenues, with a 6.2% year-over-year decrease reported for Q1 2026.

估值指標

Mannatech Inc(MTEX)目前預期本益比為 9.57,5 年平均預期本益比為 1.70。

預期本益比

嚴重高估
5 年均值 P/E
1.70
目前P/E
9.57
高估
5.22
低估
-1.83

預期 EV/EBITDA

嚴重低估
5 年均值 EV/EBITDA
0.00
目前EV/EBITDA
0.00
高估
0.00
低估
0.00

預期股價營收比

嚴重低估
5 年均值 P/S
0.00
目前P/S
0.00
高估
0.00
低估
0.00

Alphio AI 對 MTEX 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%MTEX

$9.48

情境價格

基

基準

基準 · 50%MTEX

$7.93

情境價格

悲

悲觀

悲觀 · 25%MTEX

$7.87

情境價格

事件時間軸

2026-09-24 (ET)

10:00:00

Mannatech Trading Halted Due to Volatility

2026-09-01 (ET)

16:30:00

Mannatech Board Chairman Change Announced

2026-08-14 (ET)

14:30:00

Mannatech Trading Resumes

14:30:00

Mannatech Trading Halted Due to Volatility

2026-04-07 (ET)

16:00:00

Mannatech Trading Halted Due to Volatility

資訊

MTEX 常見問題 —— 由 Alphio AI 解答

Mannatech, Incorporated is a global health and wellness solution provider. The Company develops and sells nutritional supplements, skin care and anti-aging products, and weight-management products that target optimal health and wellness. The Company's product category includes Integrative Health, Targeted Health, Weight and Fitness, Skin Care, and Essentials. Integrative Health includes Ambrotose Complex, Ambrotose AO, Advanced Ambrotose, Ambrotose Life, Catalyst, Cognitate, Manapol Powder, MannaBears, and others. Targeted Health includes BounceBack, CardioBALANCE, GI-ProBalance Slimstick, GI-Zyme, GI-Defense, Blood Sugar ProBalance, ImmunoSTART, and others. Weight and Fitness includes OsoLean, SPORT, TruHealth Fat Loss System and others. Skin Care includes Emprizone, FIRM with Ambrotose, FreshDen, and others. Essentials include Catalyst Multivitamin, Liver Support, Joint Support SUPERFOOD, Sleep Support gummies and Stress Support gummies. It operates in the Consumer Non-Cyclicals sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Mannatech Inc is not a strong buy right now due to its current price of $8.11, which is significantly below its 52-week high of $9.97. The RSI of 41.05 indicates the stock is nearing oversold territory, but the recent 5-day change of -4.25% suggests downward momentum. The upcoming earnings report on November 11 could provide more clarity on its financial health, but the company has faced declining revenues, with a 6.2% year-over-year decrease reported for Q1 2026.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易